source
- #ASGCT26: Tessera reveals strongest data yet for in vivo sickle cell therapyBOSTON — Tessera Therapeutics has created an experimental gene editing drug for sickle cell disease that could compete with commercial cell therapies but is delivered as an infusion — no complex ce…Endpoints · 3mo ago↗ source
- Extreme heat is worsening faster for Black AmericansBill Cassidy's can't-win conundrum, what RFK Jr. gets right and wrong about antidepressants, and more health newsSTAT · 3mo ago↗ source
- [Podcast] Closing the Distance in Cancer CareThis podcast episode explores the critical role community oncology plays in the U.S. healthcare system and why supporting its growth and autonomy matters for patients and providers.BioPharma Dive · 3mo ago